Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) ("Taseko" or the "Company") reports full year 2025 Adjusted EBITDA* of...
-
PITTSBURGH, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Armada has been named McDonald’s U.S. Supplier of the Year for 2025, recognizing the company’s leadership, innovation, and unwavering commitment to...
-
AMSTERDAM, N.Y., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Anthony Constantino’s campaign for Congress in NY-21 claims it calculated 3,000+ people in attendance making it the largest crowd size for a...
-
COSTA MESA, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bastion, today announced the appointment of Jody Sowa as Managing Director, Public Relations in the United States, strengthening the company’s...
-
-- Tania Markovic MBBS PhD FRACP; Jennifer L. Miller, MD; Elizabeth Roof, H.S.P., M.A.; and Theresa V. Strong, PhD; distinguished global experts in PWS, will support the Company’s PWS program, which...
-
Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "HoReCa Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's offering.This report describes and...
-
-- Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and tolerability of BMB-101 (NOVA Study) for the treatment of patients with...
-
Ad hoc announcement pursuant to Art. 53 LR Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression commonly...
-
Ad-hoc-Mitteilung gemäss Art. 53 KR Vergleichbare Langzeitwirksamkeit wie bei der Standardtherapie mit Kortikosteroiden über 5 Jahre Normales Wachstum bleibt erhalten, im Gegensatz zur...
-
Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression commonly seen with standard of care corticosteroids...